PT  - JOURNAL ARTICLE
AU  - Jordi Rello
AU  - Enrico Storti
AU  - Mirko Belliato
AU  - Ricardo Serrano
TI  - Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
AID  - 10.1183/13993003.01028-2020
DP  - 2020 May 01
TA  - European Respiratory Journal
PG  - 2001028
VI  - 55
IP  - 5
4099  - http://erj.ersjournals.com/content/55/5/2001028.short
4100  - http://erj.ersjournals.com/content/55/5/2001028.full
SO  - Eur Respir J2020 May 01; 55
AB  - Patients with COVID-19 present a broad spectrum of clinical presentation. Whereas hypoxaemia is the marker of severity, different strategies of management should be customised to five specific individual phenotypes. Many intubated patients present with phenotype 4, characterised by pulmonary hypoxic vasoconstriction, being associated with severe hypoxaemia with “normal” (>40 mL·cmH2O−1) lung compliance and likely representing pulmonary microvascular thrombosis. Phenotype 5 is often associated with high plasma procalcitonin and has low pulmonary compliance, Which is a result of co-infection or acute lung injury after noninvasive ventilation. Identifying these clinical phenotypes and applying a personalised approach would benefit the optimisation of therapies and improve outcomes.SARS-CoV-2 infections present different specific individual phenotypes. Applying a personalised approach would benefit in optimisation of therapies and outcome improvement. #COVID19 https://bit.ly/3akTSuf